Game Preview

Sigs Unit 8 Cases 8-15

  •  English    24     Public
    Review for exam
  •   Study   Slideshow
  • Rationalize the use of mannitol in acute TBI. (SIGS 8.5a)
    osmotic diuretic-- non-reabsorbable solute filtered by glomerulus causing water retention in PCT & dLoH-> alter Starling forces-> H20 leaves cells->decr ICP
  •  15
  • Discuss the use of imaging in diagnosing head trauma and differentiate subdural from epidural hematoma (Sigs 8.5a)
    non-contrast CT 1st; epidural: bright convex disc; subdural: crescent-shaped hemorrhage
  •  15
  • Explain the risk of seizure and rationale for the use of fosphenytoin for seizure prophylaxis following TBI. (Sigs 8.5a)
    H20-soluble prodrug metabol by plasma esterases->phenytoin->binds voltage-sensitive Na channel neuron->inhibit high-frequency repetitive action potentials
  •  15
  • Describe the four main symptom clusters of PTSD. (SIGS 8.5b)
    Criterion B: intrusion symp.; Criterion C: avoidance symp.; Criterion D: negative cognitions & mood; Criterion E: arousal & activity changes
  •  15
  • Explain the role of sertraline in treating PTSD. (SIGS 8.5b)
    (Zoloft)1st line monotherapy SSRI;inhibit serotonin reuptake via inhibition of SERT->incr. synaptic concentration serotonin CNS->enhanced serotonergic neurotran
  •  15
  • List the DSM-5 criteria for diagnosing PTSD. (SIGS 8.5b)
    traumatic situation-> reliving experience, avoidance, emotional detachment, incr. arousal, decr daily fx, >1 month
  •  15
  • Identify risk and protective factors for suicide. (SIGS 8.6a)
    risk: previous attempt, mental illness, social isolation, financial/legal/health problems, substance use, impulsive; protect: coping, religion, social support
  •  15
  • Describe the mechanism of action of SSRIs and SNRIs. (SIGS 8.6a)
    SSRI: inhibit 5-HT reuptake; SNRI: inhibit 5-HT & NE reuptake
  •  15
  • Explain why the therapeutic effects of SSRIs are delayed. (SIGS 8.6a)
    reuptake inhibition initially, but may require additional "downstream" effects to produce full therapeutic effect; modifies serotonergic receptors over weeks
  •  15
  • Describe neurochemical changes thought to underlie the symptoms of schizophrenia. (SIGS 8.6b)
    + symp: incr subcortical release dopamine-> augments D2 recp activation&nucleus accumben;- symp: reduced D1 recp activation prefrontal cortex & nucleus caudatus
  •  15
  • Describe how atypical antipsychotics treat symptoms of schizophrenia AND list adverse effects associated with these medications. (SIGS 8.6b)
    transiently occupy D2 recep and rapidly dissociate to allow normal dopamine transmission; 2nd gen less potent D2 antagonists + antagonize 5HT2 recep to decr AE
  •  15
  • Describe the brain circuits implicated in the symptoms of schizophrenia. (SIGS 8.6b)
    Mesolimbic Tract: + symp; Mesocortical tract: - symp and cog/affect symp
  •  15
  • List the symptoms of alcohol withdrawal and the timing of their presentation. (SIGS 8.7a)
    tremors, vomiting, anxiety, sweating tachycardia-> gen. tonic-clonic seizures-> transient hallucinations-> delirium tremens
  •  15
  • Define delirium tremens. (SIGS 8.7a)
    persistant alteration of consciousness and sympathetic hyperactivity due to alcohol withdrawal
  •  15
  • Describe withdrawal seizures. (SIGS 8.7a)
    onset 8-48 hours after cessation/reduction alcohol; usually brief, generalized tonic-clonic seizures; often single episode
  •  15
  • Explain the role of benzodiazepines in the management of alcohol withdrawal. (SIGS 8.7b)
    binds "benzodiazepine receptors" between alpha and gamma subunits of GABA-A-> incr freq. of chloride channel opening -> incr inhibitory effect of GABA
  •  15